Showing posts with label dentists. Show all posts
Showing posts with label dentists. Show all posts

Saturday, August 22, 2020

Exploring the advantages of a Virtual Compliance Assistance Partner

Challenged by increasing and changing regulations, more Compliance Officers (CO) are engaging in Virtual Compliance Assistance (VCA) as an affordable option to quickly adapt to the industry’s shifting regulatory environment, while maintaining the daily functions of the compliance program. Compliance departments, like other non-revenue-producing departments, are losing resources as hospitals and physician practices of all sizes face unprecedented financial challenges. Even before the COVID-19 pandemic, compliance departments often faced hurdles in securing adequate resources to execute their compliance work plans and support their organizations’ compliance programs.
Virtual Compliance Assistance Partner (VCAP)

Some COs find they are engaged with multiple advisors of virtual compliance services in order to meet varying needs. However, engaging a VCAP provides the greatest advantage, as it fully leverages the institutional knowledge gained as the relationship grows. A VCAP can reassure the CO and the Board that the organization is continuing to assess and mitigate risks, while adapting to a fluid regulatory environment. Further, because a compliance program seldom scales at the same pace as the organization’s growth, a VCAP can bridge gaps and minimize potential vulnerabilities. A VCAP offers a cadre of compliance advisors who can provide bandwidth, as well as a deep bench of experts who can meet nuanced compliance needs.

For example, a VCAP offers both subject matter expertise and experience, derived from working with many different clients on evolving and complex regulations that may require research and evaluation to determine the potential impact on an organization. Consequently, a VCAP can advise as to how a crisis may affect current risk exposure, and how priorities should be assessed and realigned. A VCAP can also assist with routine work plan items, as well as unexpected high-risk items that require additional resources.
Scalability

A primary advantage of a VCAP is that it can scale its services to meet the specific needs of an organization and its compliance program, regardless of size. A smaller organization may engage a VCAP to support its compliance program in totality because its compliance budget cannot support a full-time position, or partially because the individual serving in the CO role is stretched too thin serving multiple roles. A mid-to-large size organization may engage a VCAP to provide additional bandwidth to complete compliance work plan items. Any size organization can enjoy a strategic advantage by engaging a VCAP to help with specific needs, or to sustain appropriate oversight of the compliance program and support annual compliance initiatives.


Financial Flexibility


VCAPs are financially attractive to COs because they are less expensive than a full-time equivalent (FTE), yet are rich in compliance knowledge. Additionally, VCAPs are agile and can simultaneously support various needs, as well as provide immediate on-call support. VCAPs offer a resource of multiple experts in markets where demand is high. Support can be tailored to meet specific requests, and thus COs reap the maximum benefit of each compliance dollar spent.
VCAP Support

Organized in alignment with the Seven Elements of an Effective Compliance Program, VCAPs partner with and support COs by providing services to meet a variety of compliance needs. Such services include:
  • Standards, Policies, and Procedures
  • Develop and/or revise the code of conduct.
  • Develop, review, or revise compliance polices.
  • Monitor regulatory updates and develop applicable policies to address operational processes or changes, as needed.

Oversight and Program Administration

  • Develop Board and oversight responsibility education, and present as needed to Board members.
  • Develop Board reports to include the compliance program update, status of compliance work plan items, potential regulatory impacts on the organization, and ad hoc audits as identified via detected deficiencies.
  • Evaluate and/or develop the Compliance Committee infrastructure, including composition, reporting structure, and charter development.
  • Provide guidance to the CO with regard to effectively administering the compliance program and obtaining appropriate oversight.

Reporting and Investigating

  • Evaluate hotline reports and conduct necessary investigations under the direction of the CO and the organization’s legal counsel.
  • Review the entity’s investigation policy and procedure and revise as necessary.
  • Assist with processes to log and investigate issues that arise from audits performed by outside parties, such as third-party payers and government auditors.
  • Develop necessary reporting structure and tools to convey monitoring and auditing findings to executive leaders, the Board, medical staff leadership, and affected departments.
\

Education and Training


  • Monitor regulatory updates to discern impact on the organization and develop applicable training for employees and medical staff members when needed.
  • Develop the annual compliance training plan based on needs identified in the annual risk assessment, regulatory updates, and monitoring and auditing outcomes.
  • Evaluate and/or develop compliance training curriculum and materials.
  • Develop and provide annual HIPAA training.
  • Develop and provide customized compliance training for high-risk areas, such as revenue cycle and physician contracting.
  • Develop and provide specialty coding training.
  • Develop and provide professional fee coding education for providers.
  • Provide new CO training via on-site or remote “bootcamp” offerings.
  • Develop risk-based training as identified via the annual risk assessment.
  • Provide monthly/quarterly compliance “hot topic” education.


Monitoring and Auditing


  • Conduct compliance work plan audits as identified via the annual risk assessment and detected through ongoing monitoring activities.
  • Evaluate auditing and monitoring processes and controls currently in place.
  • Develop necessary processes to identify and respond to governmental payers in a timely manner.
  • Conduct auditing of facility and professional fee billed claims, for accuracy and compliance, including “audit the auditor” claims review, and follow-up audits with corresponding action plans.
  • Complete physician analytics such as E/M Bell Curve analysis, physician time study, and procedural utilization analyses to identify potential anomalies.
  • Investigate aberrant patterns by conducting a sample review of claims.
  • Monitor CMS’ Open Payment Data to identify potential undisclosed medical staff member conflicts of interest.
  • Assess physician compensation arrangements, including but not limited to, medical directorships and real estate transactions with referral sources.



Compliance Risk Assessment and Work Plan


  • Review risk assessment methodologies and tools.
  • Evaluate and prioritize identified risk items for inclusion in the compliance work plan.
  • Identify high-level risk areas that potentially expose an organization to a substantive level of threat or loss, and develop correlated prioritized action plans.

\

Response and Prevention


  • Evaluate Conflict of Interest (COI) disclosure statements and assist with necessary COI management plans.
  • Assist with development of corrective action plans and monitoring of progress of those created internally, as well as those that arise from audits performed by outside parties, such as payers and government auditors.
  • Provide exit interviews and/or exit interview templates for applicable positions to determine knowledge of potential compliance exposure.
  • Assist in developing a vendor management process, including establishing safeguards for vendor selection, implementing controls for monitoring vendor contract terms, and providing vendor compliance training.


Enforcement and Discipline


  • Review/revise content of the disciplinary policy, including sanctions for non-compliance.
  • Assist with establishing compliance goals within job descriptions and annual performance evaluations.
  • Assist with the development of disciplinary action documentation in response to issues of non-compliance.

Regulatory Compliance Assistance


  • Provide assistance with and advise organizations on navigating a corporate integrity agreement (CIA), including but not limited to:

  • Providing subject matter expertise as it relates to understanding the CIA requirements and the impact on an organization.
  • Evaluating gaps in the current compliance program, and developing mitigation plans that include timelines, accountability, and internal reporting.
  • Assisting with implementation of mitigation measures and regular reporting to the monitor.
  • Conduct transactional due diligence to evaluate potential compliance risks as they relate to program infrastructure, referral relationships, and claims submission.
  • Provide post-transaction compliance assistance in transitioning entities to a corporate compliance program (e.g., implementing compliance policies and procedures at the new entity).
  • Provide regulatory expertise as it relates to COVID-19, such as the Paycheck Protection Program, Medicare Advance Payments, and Provider Relief Funds.

Virtual Compliance Assistance Models


Depending on the size and compliance needs of an organization, VCA models will vary. The most basic model may be a flat fee per month for an established set of hours, to be used at the CO’s discretion. This model is typically used for more advanced compliance programs that simply need expertise as regulations change or new ones develop.

More advanced models will build upon themselves and may include a variety of the “a la carte” assistance outlined earlier. The advantage of VCA and a VCAP is the flexible budgetary possibilities that offer customizable options maximizing the value of every dollar invested in an organization’s compliance program.

Conclusion


When effectively deployed, a VCAP is not only economically efficient in that it consolidates the role of multiple advisors, it also garners increased executive and shareholder confidence because of the expertise it offers. A VCAP provides sustainability to compliance programs that otherwise might struggle to appropriately support the organization. Working as a trusted and valued member of your team, a VCAP gains the institutional knowledge of the organization and compliance program, resulting in efficiencies and the most value for building and supporting a robust compliance program.


Take Aways

  1. VCA is an affordable option to quickly adapt to changing regulations, while maintaining a compliance program’s daily function.
  2. A VCAP can reassure the CO and Board that the organization is continuing to assess and mitigate risks while adapting to regulatory changes.
  3. A VCAP can bridge gaps and minimize potential vulnerabilities when a compliance program does not scale at the same pace of the organization’s growth.
  4. VCAPs are financially attractive to COs, offering multiple experts, and providing tailored support at a lower cost than an FTE.
  5. VCAPs can become trusted, valued team members, providing sustainability to compliance programs that otherwise might struggle to appropriately support the organization.

Medical Practice Supplies


VIEW ALL



Manual Prescription Pad (Large - Yellow)


Manual Prescription Pad (Large - Pink)

Manual Prescription Pads (Bright Orange)

Manual Prescription Pads (Light Pink)

Manual Prescription Pads (Light Yellow)

Manual Prescription Pad (Large - Blue)

Manual Prescription Pad (Large - White)

VIEW ALL

Thursday, August 13, 2020

COVID Testing: What’s appropriate and what’s not

As the COVID-19 landscape becomes more familiar, patients, practitioners, and insurance companies should be vigilant about schemes and the submission of false claims for payment. Two areas in particular which come to mind are offering free COVID-19 antibody testing and coding. The scheme is, a patient contacts his/her doctor thinking they may have COVID-19. The patient wants a COVID-19 test. The doctor tests them for COVID-19, but adds on the COVID-19 antibody test and various allergy tests. Instead of charging $100-$150 test, the physician bills around $500 for this test bundle. What are the implications for the physician’s actions?

First, the offering of free goods or services in exchange for the referral of patients or increased utilization should always be checked for compliance with the Federal Anti-Kickback Statute, Stark Law, and related state laws, such as the California Insurance Fraud Prevention Act. Despite the Centers for Medicare and Medicaid Services (CMS) issuing several “1135 Waivers” during the COVID-19 pandemic, which impact the AKS and Stark Law, “[p]roviders must meet specific requirements to take advantage of the waivers.”

For example, the U.S. Department of Health and Human Services, Office of the Inspector General (HHS-OIG) issued responses to various questions, with the caveat that the facts and circumstances may change the response and the liability. One question (and the answer) is particularly relevant to this article.

Q: Can clinical laboratories offer free COVID-19 antibody testing to Federal health care program beneficiaries who are contemporaneously receiving other medically necessary blood tests during the COVID-19 public health emergency?


A: (Posted August 4, 2020) - According to the facts presented, a clinical laboratory would provide free COVID-19 antibody testing to patients, including Federal health care program beneficiaries, who contemporaneously undergo other medically necessary blood tests performed by the laboratory. The laboratory's stated purpose for the arrangement is to increase patient awareness of antibodies to promote donations of COVID-19 blood plasma, which could be used for certain experimental convalescent plasma therapy treatments for COVID-19. The laboratory would not charge any patient or other payor for the COVID-19 antibody tests. Patients and physicians would be able to access COVID-19 antibody testing results through the laboratory's patient portal, and the results from the antibody testing program also would be reported to the Centers for Disease Control and Prevention and State public health agencies to further support COVID-19 surveillance and response efforts.
Providing free laboratory testing to Federal health care program beneficiaries implicates the Federal anti-kickback statute because the clinical laboratory would be providing something of value for free to beneficiaries who could self-refer to the laboratory for items and services reimbursable by a Federal health care program. The proposed arrangement also implicates the Beneficiary Inducements CMP because the free COVID-19 antibody testing could reasonably influence a Medicare or State health care program beneficiary to select—or to cause his or her physician to select—the clinical laboratory for other medically necessary blood testing that is reimbursable by Medicare or a State health care program, in order to qualify for the free COVID-19 antibody testing.

We believe the proposed arrangement offers the possibility of substantial public health benefits through the identification of additional potential convalescent plasma donors and valuable public health information and data and would pose a sufficiently low risk of fraud and abuse, provided the proposed arrangement includes the following safeguards: (1) the physicians ordering the laboratory tests, including the free COVID-19 antibody tests, would not receive any payments or anything else of value from the clinical laboratory in connection with the free antibody testing program; (2) the patients receiving the laboratory tests would not receive any payments or anything of value, other than the free COVID-19 antibody test, from the clinical laboratory in connection with the free antibody testing program; (3) the tests would be offered only to patients receiving other medically necessary blood tests as part of a medically necessary exam or treatment; (4) no payor, including the patient, a commercial insurance company, or a Federal health care program, would be billed for or pay any costs in connection with the COVID-19 antibody tests; and (5) the antibody tests are cleared or approved by the U.S. Food and Drug Administration (FDA) or are subject to an FDA-issued Emergency Use Authorization.

In other words, the five (5) conditions must be met in order to make this scenario unlikely to be prosecuted for violating the AKS.

The question still remains, what coding is appropriate? In April 2020, CMS-Ruling 2020-1-R was issued by CMS. Notably, the codes that need to be utilized, as well as the payment rate of $100 were expressly stated.

With regard to CDLTs that make use of high throughput technologies (as defined in this Ruling), are administered during the ongoing emergency period defined in paragraph (1)(B) of section 1135(g) of the Act beginning on or after March 18, 2020, for the detection of SARS–CoV–2 or the diagnosis of the virus that causes COVID–19, and are a type of CDLT currently paid for under Medicare Part B using CPT code 87635 or U0002, such tests, as identified using U0003 or U0004 as appropriate, shall be paid for at the rate of $100. Payment for all other CDLTs remains at the current level.

CMS intends to promptly evaluate payment for relevant CDLTs for COVID-19 testing that make use of high throughput technologies developed after this issuance upon request for payment at an appropriate rate.

Neither code CPT U0003 nor CPT U0004 is permissible for tests detecting COVID-19 antibodies. “It is noted that U003 should identify tests that would otherwise be identified by CPT code 87635 but for being performed with these high throughput technologies.”

To answer the initial question regarding the implications for the physician - bundling these various tests in order to maximize reimbursement and add on unnecessary tests (e.g., allergy tests) that are not related to COVID-19 could be considered upcoding by providers and result in civil and/or criminal penalties under the False Claims Act or a similar state statute, such as the California IFPA.

Medical Practice Supplies


VIEW ALL



Manual Prescription Pad (Large - Yellow)


Manual Prescription Pad (Large - Pink)

Manual Prescription Pads (Bright Orange)

Manual Prescription Pads (Light Pink)

Manual Prescription Pads (Light Yellow)

Manual Prescription Pad (Large - Blue)

Manual Prescription Pad (Large - White)

VIEW ALL

Monday, July 27, 2020

Healthcare data sharing needs a major overhaul

Across all sectors of the healthcare ecosystem, there’s dire need for a technological advancement to improve data sharing. If any event displays this disparity in the healthcare system so clearly, it’s COVID-19.

Researchers have called out the challenges public health agencies face accessing disparate data from key participants in the pandemic’s management. But it’s not just a problem amidst coronavirus—it’s an issue across the board, even in our most mundane days on the job.

Every corner of the field—from physicians’ private practices to large medical groups, inpatient to outpatient care, genomics, labs, health plans, and beyond—exhibits a clear void in efficient data and file sharing technology. For example, today, a patient is often required to physically pick up a CD/DVD from their radiologist to share their records with the specialist. Not only does this old process cause a delay in patient care but also continues the path of fragmented care.

With the 21st Century CURES Act coming into effect, organizations are required to improve their interoperability. But how can they when so many healthcare professionals are still relying on outdated systems like the fax machine, which has long been phased out of virtually every other field.


HIPAA requirements pose a necessary hurdle for what technology can be implemented, but compliant solutions exist that can be applied right now. With so much change and progress occurring in medicine, health and wellness, our use of technology must follow suit, so we can better share research, resources, patient data and other vital information in a more efficient and effective way.

Beyond the CURES Act requirements, improved file sharing is critical for enabling physicians to empower their patients’ engagement. Safely and securely transferring data for imaging and rich-media files can be expedited, claims data can be streamlined between payers and providers, and research centers can be enriched by enhanced IOP.

One glaring element of caution to consider when implementing any new software application is “the cloud.” This ambiguous data storage experiment is riddled with security breaches, data leaks and potential risks that may expose confidential information or result in a total loss of files, especially if no backup is available. When sharing files over cloud-based tools, you’re essentially relying on a vulnerable third party to pass your data along. Furthermore Accurics, a cloud-computing security firm, found that only four percent of issues reported in cloud production environments are being addressed, highlighting a startling fissure if using cloud-based software. And researchers from the cloud security company DivvyCloud found that breaches caused by cloud misconfigurations cost companies worldwide an estimated $5 trillion in 2018 and 2019.

There’s also a need for better mapping on the back end of healthcare computer networks, which is an issue in the hands of many EHR systems. Almost all healthcare environments have been structured uniquely from one another, often making it difficult to effectively transfer files within their own healthcare networks. It’s up to EHRs to create solutions that improve these workflows, particularly with interoperability, so file sharing solutions can work seamlessly on day one.


With such disparate systems in place, the technology advancement healthcare workers desperately need may not seem like a simple task on the surface, but it can and should happen sooner rather than later. Proper efforts to strategize with IT teams and organizational leadership can result in significant improvements when better data sharing technology is implemented.

This is an evolution that can arrive now, at low costs, with minimal training needed. It’s time the healthcare industry stepped into the future to meet the standards of today’s patients and the rest of the working world.

Medical Practice Supplies


VIEW ALL



Manual Prescription Pad (Large - Yellow)


Manual Prescription Pad (Large - Pink)

Manual Prescription Pads (Bright Orange)

Manual Prescription Pads (Light Pink)

Manual Prescription Pads (Light Yellow)

Manual Prescription Pad (Large - Blue)

Manual Prescription Pad (Large - White)

VIEW ALL